• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

科学偏见对 2019 冠状病毒病草药的危害。

Dangers of scientific bias against herbal drugs for coronavirus disease 2019.

机构信息

Integrative Medicine US, Tamarac, FL 33321, USA.

出版信息

J Integr Med. 2020 Nov;18(6):459-461. doi: 10.1016/j.joim.2020.09.005. Epub 2020 Sep 18.

DOI:10.1016/j.joim.2020.09.005
PMID:33008774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7498439/
Abstract

On May 15, 2020, the Lancet published an article titled Use of Herbal Drugs to Treat COVID-19 Should be with Caution. While this is true of all drugs, herbal and otherwise, the data may be biased and deserve a scientific response. We believe these types of reports will unfairly and negatively impact the field of integrative medicine as a whole, and must be answered with facts and statistics that more accurately represent the current situation.

摘要

2020 年 5 月 15 日,《柳叶刀》发表了一篇题为《使用草药药物治疗 COVID-19 应谨慎》的文章。虽然这对所有药物(草药和非草药药物)都是如此,但这些数据可能存在偏差,值得进行科学回应。我们认为,这类报告将不公平且负面地影响整个整体医学领域,必须用更准确反映当前情况的事实和统计数据来回应。

相似文献

1
Dangers of scientific bias against herbal drugs for coronavirus disease 2019.科学偏见对 2019 冠状病毒病草药的危害。
J Integr Med. 2020 Nov;18(6):459-461. doi: 10.1016/j.joim.2020.09.005. Epub 2020 Sep 18.
2
Chinese herbal medicine supplementation therapy on COVID-19.中药补充疗法治疗新型冠状病毒肺炎
Pharmacol Res. 2020 Oct;160:105181. doi: 10.1016/j.phrs.2020.105181. Epub 2020 Aug 29.
3
Global research trends at the intersection of coronavirus disease 2019 (COVID-19) and traditional, integrative, and complementary and alternative medicine: a bibliometric analysis.全球研究趋势交汇于 2019 年冠状病毒病(COVID-19)与传统、整体、补充和替代医学:文献计量分析。
BMC Complement Med Ther. 2020 Nov 23;20(1):353. doi: 10.1186/s12906-020-03151-8.
4
Use of herbal drugs to treat COVID-19 should be with caution.使用草药治疗新冠病毒疾病时应谨慎。
Lancet. 2020 May 30;395(10238):1689-1690. doi: 10.1016/S0140-6736(20)31143-0. Epub 2020 May 15.
5
Databases for facilitating mechanistic investigations of traditional Chinese medicines against COVID-19.促进中药抗COVID-19机制研究的数据库
Pharmacol Res. 2020 Sep;159:104989. doi: 10.1016/j.phrs.2020.104989. Epub 2020 Jun 2.
6
Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective.中药治疗 2019 年新型冠状病毒(SARS-CoV-2)感染患者:综述与展望。
Int J Biol Sci. 2020 Mar 15;16(10):1708-1717. doi: 10.7150/ijbs.45538. eCollection 2020.
7
East meets West in COVID-19 therapeutics.在新冠病毒治疗中,东西方相遇了。
Pharmacol Res. 2020 Sep;159:105008. doi: 10.1016/j.phrs.2020.105008. Epub 2020 Jun 9.
8
Traditional Chinese Medicine treatment of COVID-19.中医药治疗 COVID-19。
Complement Ther Clin Pract. 2020 May;39:101165. doi: 10.1016/j.ctcp.2020.101165. Epub 2020 Apr 1.
9
The effectiveness and safety of traditional Chinese medicine for the treatment of children with COVID-19.中药治疗儿童新型冠状病毒肺炎的有效性和安全性。
Medicine (Baltimore). 2020 Jul 24;99(30):e21247. doi: 10.1097/MD.0000000000021247.
10
Network pharmacological approach for elucidating the mechanisms of traditional Chinese medicine in treating COVID-19 patients.基于网络药理学方法阐释中药治疗新冠肺炎患者的作用机制
Pharmacol Res. 2020 Sep;159:105043. doi: 10.1016/j.phrs.2020.105043. Epub 2020 Jun 20.

引用本文的文献

1
The Dynamics of Power Flow From the Global Health Financing Comment on "Power Dynamics Among Health Professionals in Nigeria: A Case Study of the Global Fund Policy Process".全球卫生筹资评论中的权力流动动态:以尼日利亚卫生专业人员的权力动态为例研究全球基金政策进程。
Int J Health Policy Manag. 2023;12:7806. doi: 10.34172/ijhpm.2023.7806. Epub 2023 May 10.
2
Complementary and alternative medicine during COVID-19 pandemic: What we have done.2019冠状病毒病大流行期间的补充和替代医学:我们所做的工作。
J Integr Med. 2022 Jan;20(1):1-3. doi: 10.1016/j.joim.2021.11.008. Epub 2021 Nov 27.

本文引用的文献

1
Use of herbal drugs to treat COVID-19 should be with caution.使用草药治疗新冠病毒疾病时应谨慎。
Lancet. 2020 May 30;395(10238):1689-1690. doi: 10.1016/S0140-6736(20)31143-0. Epub 2020 May 15.
2
Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective.中药治疗 2019 年新型冠状病毒(SARS-CoV-2)感染患者:综述与展望。
Int J Biol Sci. 2020 Mar 15;16(10):1708-1717. doi: 10.7150/ijbs.45538. eCollection 2020.
3
Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2).连花清瘟对新型冠状病毒(SARS-CoV-2)具有抗病毒和抗炎作用。
Pharmacol Res. 2020 Jun;156:104761. doi: 10.1016/j.phrs.2020.104761. Epub 2020 Mar 20.
4
Prevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysis.医疗保健环境中可预防的患者伤害的发生率、严重程度和性质:系统评价和荟萃分析。
BMJ. 2019 Jul 17;366:l4185. doi: 10.1136/bmj.l4185.
5
Tu Youyou winning the Nobel Prize: Ethical research on the value and safety of traditional Chinese medicine.屠呦呦获诺贝尔奖:中药伦理研究的价值与安全。
Bioethics. 2020 Feb;34(2):166-171. doi: 10.1111/bioe.12456. Epub 2018 Jul 3.
6
The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function.中药方剂连花清瘟胶囊通过抑制病毒增殖发挥抗流感活性,并影响免疫功能。
BMC Complement Altern Med. 2017 Feb 24;17(1):130. doi: 10.1186/s12906-017-1585-7.
7
Unnecessary prescribing of NSAIDs and the management of NSAID-related gastropathy in medical practice.医疗实践中非甾体抗炎药的不必要处方及非甾体抗炎药相关性胃病的管理
Ann Intern Med. 1997 Sep 15;127(6):429-38. doi: 10.7326/0003-4819-127-6-199709150-00003.
8
Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs.年轻女性快速进展性间质性肾纤维化:与包括中草药在内的减肥方案的关联。
Lancet. 1993 Feb 13;341(8842):387-91. doi: 10.1016/0140-6736(93)92984-2.